» Articles » PMID: 4362410

Experimental Pertussis Infection in the Marmoset: Type Specificity of Active Immunity

Overview
Journal J Hyg (Lond)
Specialty Public Health
Date 1974 Apr 1
PMID 4362410
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

ALTHOUGH WE HAVE FAILED TO PRODUCE EITHER PAROXYSMAL COUGH OR VOMITING IN RHESUS MONKEYS, CYNOMOLGUS MONKEYS AND MARMOSETS, WE HAVE FOUND IN MARMOSETS SEVERAL FEATURES OF PERTUSSIS INFECTION SIMILAR TO THOSE SEEN IN CHILDREN WITH WHOOPING COUGH: catarrh, persistence of colonization of the naso-pharynx with Bordetella pertussis for 4-11 weeks, change of serotype during colonization and inability of type 1 organisms to establish themselves as the predominant serotype.As in children, we have found that intramuscular vaccine of type 1,2,3 was more effective than type 1,2 in preventing persistent infection with the currently prevalent serotypes 1,2,3 and 1,3. A mixed vaccine (1,2,3 and 1,3) seemed to produce agglutinin 3 in the serum more consistently than a pure type 1,2,3 vaccine. The duration of colonization, after naso-pharyngeal challenge, was greatly reduced in animals with agglutinin 3.Local immunity, resulting from previous infection, was even more effective than a good vaccine in preventing subsequent persistent colonization. Marmosets may be useful in studying the possible development of aerosol pertussis vaccine for human use.

Citing Articles

Non-primate animal models for pertussis: back to the drawing board?.

Cimolai N Appl Microbiol Biotechnol. 2022; 106(4):1383-1398.

PMID: 35103810 PMC: 8803574. DOI: 10.1007/s00253-022-11798-1.


Aerosol infection of mice with Bordetella pertussis.

Sato Y, Izumiya K, Sato H, Cowell J, MANCLARK C Infect Immun. 1980; 29(1):261-6.

PMID: 6249758 PMC: 551104. DOI: 10.1128/iai.29.1.261-266.1980.


Variation of serotype in strains of Bordetella pertussis.

Stanbridge T, PRESTON N J Hyg (Lond). 1974; 73(2):305-10.

PMID: 4370715 PMC: 2130318. DOI: 10.1017/s0022172400024165.


Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

PRESTON N J Hyg (Lond). 1976; 77(1):85-91.

PMID: 185285 PMC: 2129724. DOI: 10.1017/s0022172400055546.


The stability of the serotypes of Bordetella pertussis with particular reference to serotype 1,2,3,4.

Dolby J J Hyg (Lond). 1976; 76(2):277-86.

PMID: 177704 PMC: 2129616. DOI: 10.1017/s0022172400055170.


References
1.
Evans D, Perkins F . Interference immunity produced by pertussis vaccine to pertussis infection in mice. Br J Exp Pathol. 1954; 35(6):603-8. PMC: 2073676. View

2.
Abbott J, PRESTON N, Mackay R . Agglutinin response to pertussis vaccination in the child. Br Med J. 1971; 1(5740):86-8. PMC: 1795673. DOI: 10.1136/bmj.1.5740.86. View

3.
PRESTON N, Stanbridge T . Efficacy of pertussis vaccines: a brighter horizon. Br Med J. 1972; 3(5824):448-51. PMC: 1786017. DOI: 10.1136/bmj.3.5824.448. View

4.
PILLEMER L, Blum L, Lepow I . Protective antigen of haemophilus pertussis. Lancet. 1954; 266(6825):1257-60. DOI: 10.1016/s0140-6736(54)92770-1. View

5.
ANDERSEN E . Serological studies on H. pertussis H. parapertussis and H. bronchisepticus. Acta Pathol Microbiol Scand. 1953; 33(2):202-24. DOI: 10.1111/j.1699-0463.1953.tb01512.x. View